Home / Inspections / 1253016

FDA Inspection 1253016 — Central Pennsylvania Blood Bank

Central Pennsylvania Blood Bank — FEI 1000307044

The FDA completed an inspection of Central Pennsylvania Blood Bank on October 24, 2024 in Harrisburg, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 24, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Harrisburg, PA (United States)

Facility

Other inspections at this facility

  • 1115165 (NAI Fri Jan 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1037735 (NAI Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888329 (NAI Thu Jul 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 794471 (NAI Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 701117 (NAI Thu Dec 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources